Context Therapeutics Reports Second Quarter 2024 Operating and Financial Results
Go back to Context Therapeutics Reports Second Quarter 2024 Operating and Financial Results| (NASDAQ: CNTX) | Delayed: 0.50 +0.01 (2.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.49 | 52 Week High | $ | |||
| Open | $0.49 | 52 Week Low | $ | |||
| Day High | $0.50 | P/E | N/A | |||
| Day Low | $0.48 | EPS | $ | |||
| Volume | 330,179 | |||||

